Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
3.
Int J Cardiol ; 167(6): 2555-60, 2013 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-22805550

RESUMEN

BACKGROUND: Patients with Fabry disease (FD) develop progressive left ventricular hypertrophy (LVH). In screening studies in patients with LVH, the prevalence of FD ranges from 0 to 12%. This variability is attributable to different factors like diverging inclusion and exclusion criteria, the evaluation of selected populations and suboptimal screening methods. In this study, we aimed to determine the prevalence of FD in an unselected population of everyday clinical practice presenting LVH, defined as a maximal end-diastolic septal or posterior wall thickness ≥ 13 mm, without exclusion of patients with arterial hypertension or valvular pathology, and using optimal screening methods. METHODS: In adult males, a two-tier approach was used; α-Galactosidase A (aGAL A) activity was measured using a dried bloodspot test (DBS) and diagnosis was confirmed by mutation analysis of the GLA gene. In females, mutation analysis was the primary screening tool. RESULTS: 362 men and 178 women were screened. Six patients were diagnosed with a genetic sequence alteration of the GLA gene. One man had a novel mutation, GLA p.Ala5Glu (c.44C>A), presenting as classical FD. Another man and three women had the previously described GLA p.Ala143Thr (c.427G>A) mutation, which generally presents as an attenuated phenotype. One woman had a novel sequence alteration c.639+6A>C, which appeared to be a polymorphism. All true Fabry patients had arterial hypertension (AHT), and one had hypertrophic obstructive cardiomyopathy (HOCM). CONCLUSIONS: In a group of unselected patients with LVH, we found a prevalence of Fabry disease of 0.9%. AHT or type of hypertrophy should not be an exclusion criterion for screening for FD.


Asunto(s)
Enfermedad de Fabry/diagnóstico , Enfermedad de Fabry/epidemiología , Hipertensión/diagnóstico , Hipertensión/epidemiología , Hipertrofia Ventricular Izquierda/diagnóstico , Hipertrofia Ventricular Izquierda/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Análisis Mutacional de ADN/métodos , Pruebas con Sangre Seca/métodos , Enfermedad de Fabry/genética , Femenino , Humanos , Hipertensión/genética , Hipertrofia Ventricular Izquierda/genética , Masculino , Persona de Mediana Edad , Linaje , Prevalencia , Adulto Joven , alfa-Galactosidasa/genética
6.
Resuscitation ; 71(2): 260-2, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16987579

RESUMEN

Survival after prolonged cardiopulmonary resuscitation (CPR) is often associated with neurological and other sequelae. We describe a patient who survived prolonged cardiac arrest due to ventricular fibrillation neurologically intact but suffered colon ischaemia and necrosis in the post-resuscitation period. Subtotal colectomy was performed. We wonder whether this complication was related to the use of vasopressin.


Asunto(s)
Reanimación Cardiopulmonar/efectos adversos , Colon/irrigación sanguínea , Colon/patología , Isquemia/etiología , Agonistas Adrenérgicos/uso terapéutico , Adulto , Amiodarona/uso terapéutico , Antiarrítmicos/uso terapéutico , Colectomía , Colon/cirugía , Cardioversión Eléctrica , Epinefrina/uso terapéutico , Femenino , Paro Cardíaco/terapia , Humanos , Isquemia/cirugía , Necrosis/etiología , Necrosis/cirugía , Factores de Tiempo , Vasoconstrictores/uso terapéutico , Vasopresinas/uso terapéutico , Fibrilación Ventricular/terapia
7.
Int J Cardiol ; 110(1): 114-5, 2006 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-16005088

RESUMEN

May-Thurner syndrome is an uncommon process in which the right common iliac artery compresses the left common iliac vein, possibly resulting in pain, severe edema of the left leg or in left iliofemoral deep vein thrombosis [May R, Thurner J. The cause of the predominately sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957; 8: 419-427 .]. Corrective surgical treatment requires extensive dissection. Therefore, endovascular venous stenting is currently used in these patients [Lamont JP, Pearl GJ, Patetsios P, Warner MT, Gable DR, Garrett W, et al. Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner syndrome. Ann Vasc Surg. 2002 Jan; 16(1): 61-4. Epub 2002 Jan 17 .]. We present a case of migration of two iliacal vein stents into the right ventricle in a patient with May-Thurner syndrome.


Asunto(s)
Migración de Cuerpo Extraño/etiología , Vena Ilíaca , Enfermedades Vasculares Periféricas/complicaciones , Stents , Disfunción Ventricular Derecha/etiología , Constricción Patológica/complicaciones , Femenino , Humanos , Arteria Ilíaca , Persona de Mediana Edad , Síndrome
8.
Eur J Echocardiogr ; 7(4): 336-8, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16095974

RESUMEN

This case illustrates the Eustachian valve as an ambiguous entity. By tethering a thrombus the valve prevented a major pulmonary embolism. However, in combination with a patent foramen ovale, it directs the thrombus into the left atrium, creating a threat for systemic embolisms.


Asunto(s)
Cardiopatías/diagnóstico por imagen , Defectos del Tabique Interatrial/diagnóstico por imagen , Embolia Pulmonar , Trombosis/diagnóstico por imagen , Vena Cava Inferior/anomalías , Ecocardiografía Transesofágica , Femenino , Defectos del Tabique Interatrial/complicaciones , Humanos , Neoplasias Ováricas/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...